Tg Therapeutics, Inc. (NASDAQ:TGTX) is held by 341 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 21,848,462 | 548,037 | 2.57% | $651,302,651.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 15,841,002 | 319,703 | 2.06% | $472,220,271.00 |
| State Street Corp | 31 Dec, 2025 | 8,479,999 | 379,380 | 4.68% | $252,788,770.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 4,102,264 | 2,582,891 | 170.00% | $122,288,488.00 |
| Clearbridge Investments, LLC | 31 Dec, 2025 | 3,448,033 | -1,196,442 | -25.76% | $102,785,853.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,403,866 | -40,053 | -1.16% | $101,482,782.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 3,139,312 | -705,419 | -18.35% | $93,582,891.00 |
| CONGRESS ASSET MANAGEMENT CO | 31 Dec, 2025 | 1,922,410 | 1,922,410 | 0.00% | $57,307,042.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,609,815 | 515,481 | 47.10% | $47,988,585.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 1,581,234 | 28,446 | 1.83% | $47,136,586.00 |
| Morgan Stanley | 31 Dec, 2025 | 1,503,037 | 255,236 | 20.45% | $44,805,561.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 1,461,048 | -148,503 | -9.23% | $43,553,841.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,419,519 | -82,214 | -5.47% | $42,315,861.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,311,689 | 1,532 | 0.12% | $39,101,449.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,060,448 | 170,578 | 19.17% | $31,611,955.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,011,037 | 18,334 | 1.85% | $30,139,013.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 969,975 | -158,785 | -14.07% | $28,914,955.00 |
| Man Group plc | 31 Dec, 2025 | 956,637 | -51,825 | -5.14% | $28,517,349.00 |
| Nuveen, LLC | 31 Dec, 2025 | 953,206 | 242,434 | 34.11% | $28,415,072.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 898,409 | 25,858 | 2.96% | $26,781,579.00 |